61
Views
25
CrossRef citations to date
0
Altmetric
Article

Human Eukaryotic Release Factor 3a Depletion Causes Cell Cycle Arrest at G1 Phase through Inhibition of the mTOR Pathway

, &
Pages 5619-5629 | Received 08 Jan 2007, Accepted 30 May 2007, Published online: 01 Apr 2023
 

Abstract

Eukaryotic release factor 3 (eRF3) is a GTPase associated with eRF1 in a complex that mediates translation termination in eukaryotes. Studies have related eRF3 with cell cycle regulation, cytoskeleton organization, and tumorigenesis. In mammals, two genes encode two distinct forms of eRF3, eRF3a and eRF3b, which differ in their N-terminal domains. eRF3a is the major factor acting in translation termination, and its expression level controls termination complex formation. Here, we investigate the role of eRF3a in cell cycle progression using short interfering RNAs and flow cytometry. We show that eRF3a depletion induces a G1 arrest and that eRF3a GTP-binding activity, but not the eRF3a N-terminal domain, is required to restore G1-to-S-phase progression. We also show that eRF3a depletion decreases the global translation rate and reduces the polysome charge of mRNA. Finally, we show that two substrates of the mammalian TOR (mTOR) kinase, 4E-BP1 and protein kinase S6K1, are hypophosphorylated in eRF3a-depleted cells. These results strongly suggest that the G1 arrest and the decrease in translation induced by eRF3a depletion are due to the inhibition of mTOR activity and hence that eRF3a belongs to the regulatory pathway of mTOR activity.

This work was supported by the Association Française contre les Myopathies and by the Association pour la Recherche sur le Cancer (grant no. 3784). Céline Chauvin held fellowships from the French Ministère de la Recherche et de l'Enseignement Supérieur, from the Fondation pour la Recherche Médicale, and from the Société Française du Cancer.

We thank Michel Kress, Sophie Bellanger, and Olivier Ganier for their help in videomicroscopy and cell cycle analyses. We thank Isabelle Dusanter-Fourt and Mario Pende for the generous gift of the antibodies directed against proteins involved in the mTOR signaling pathway.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.